Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Corium Intl (CORI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 285,934
  • Shares Outstanding, K 36,240
  • Annual Sales, $ 31,860 K
  • Annual Income, $ -47,790 K
  • 36-Month Beta 1.55
  • Price/Sales 9.05
  • Price/Cash Flow N/A
  • Price/Book 7.92

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.57 +5.02%
on 07/02/18
9.00 -11.67%
on 06/26/18
-0.95 (-10.67%)
since 06/22/18
3-Month
7.57 +5.02%
on 07/02/18
10.45 -23.92%
on 04/24/18
-2.51 (-24.00%)
since 04/23/18
52-Week
7.24 +9.81%
on 08/10/17
13.93 -42.93%
on 01/22/18
-0.92 (-10.37%)
since 07/21/17

Most Recent Stories

More News
Corium Announces Issuance of Additional U.S. Patent Covering Corplex(TM) Donepezil Transdermal System for Alzheimer's Disease

Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that...

CORI : 7.93 (+0.51%)
Corium Announces Issuance of Key U.S. Patent Covering Corplex(TM) Donepezil Transdermal System for Alzheimer's Disease

Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that...

CORI : 7.93 (+0.51%)
New Research Coverage Highlights Monolithic Power, Ulta Beauty, Twenty-First Century Fox, Corium International, Independence Realty Trust, and Babcock & Wilcox Enterprises -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Monolithic Power Systems, Inc....

ULTA : 257.14 (+1.03%)
FOXA : 46.01 (+0.02%)
BW : 2.30 (-4.17%)
MPWR : 141.61 (+0.63%)
IRT : 9.91 (-0.70%)
CORI : 7.93 (+0.51%)
FOX : 45.63 (-0.13%)
Moving Average Crossover Alert: Corium International, Inc. (CORI)

Moving Average Crossover Alert: Corium International, Inc. (CORI)

CORI : 7.93 (+0.51%)
Corium International, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Corium International, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on May 14, 2018 at 5:00 PM Eastern Time.

CORI : 7.93 (+0.51%)
Corium Reports Second Quarter Fiscal 2018 Financial Results and Corporate Highlights

Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited...

CORI : 7.93 (+0.51%)
Corium to Report Second Quarter Fiscal 2018 Financial Results on Monday, May 14, 2018

Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the second quarter ended March 31, 2018 on Monday, May 14, 2018 after the close of the U.S. financial...

CORI : 7.93 (+0.51%)
Why the Earnings Streak Will Continue for Corium International (CORI)

Corium International (CORI) is in a good position to beat earnings at its next report as it has a favorable Zacks Rank and positive Earnings ESP.

CORI : 7.93 (+0.51%)
Edible Electronic Circuits Could be a Medical Revolution in the Waiting

FN Media Group Presents USA News Group News Commentary

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
BSX : 33.67 (-0.30%)
SUPN : 55.85 (+1.77%)
BDX : 248.13 (+0.45%)
BAX : 74.85 (-0.20%)
CORI : 7.93 (+0.51%)
AXSM : 3.10 (-1.59%)
CymaBay Therapeutics (CBAY) in Focus: Stock Moves 11.4% Higher

CymaBay Therapeutics (CBAY) was a big mover last session, as the company saw its shares rise more than 11% on the day.

CBAY : 12.40 (-0.40%)
CORI : 7.93 (+0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade CORI with:

Business Summary

Corium International, Inc. is a commercial-stage biopharmaceutical company. It is focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage advanced technologies in transdermal and transmucosal delivery systems. Corium has developed six marketed...

See More

Key Turning Points

2nd Resistance Point 8.10
1st Resistance Point 7.99
Last Price 7.93
1st Support Level 7.83
2nd Support Level 7.78

See More

52-Week High 13.93
Fibonacci 61.8% 11.37
Fibonacci 50% 10.59
Fibonacci 38.2% 9.80
Last Price 7.93
52-Week Low 7.24

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar